Back
Prelude Therapeutics 10K Form
Sell
21
PRLD
Prelude Therapeutics
Last Price:
1.15
Seasonality Move:
21.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-11 | 10Q | PRLD/Prelude Therapeutics Quarterly |
| 2021-03-16 | 10K | PRLD/Prelude Therapeutics Annual |
| 2020-11-10 | 10Q | PRLD/Prelude Therapeutics Quarterly |
Receive PRLD News And Ratings
See the #1 stock for the next 7 days that we like better than PRLD
PRLD Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-27.36M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.84 |
| Price / Book: | 0.42 |
Profitability
| EPS (TTM): | -1.78000 |
|---|---|
| Net Income (TTM): | $-131.52M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Prelude Therapeutics Earnings Forecast
Key Prelude Therapeutics Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 2 years.
Prelude Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PRLD |
| CUSIP: | 74065P |
| Website: | preludetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.04 |
| Quick Ratio: | 6.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRLD Technical Analysis vs Fundamental Analysis
Sell
21
Prelude Therapeutics (PRLD)
is a Sell
Is Prelude Therapeutics a Buy or a Sell?
-
Prelude Therapeutics stock is rated a Sell
The current Prelude Therapeutics [PRLD] share price is $1.20. The Score for PRLD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.